Your browser doesn't support javascript.
loading
Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma.
Song, Shaoming; Bai, Mingzhen; Li, Xiaofei; Gong, Shiyi; Yang, Wenwen; Lei, Caining; Tian, Hongwei; Si, Moubo; Hao, Xiangyong; Guo, Tiankang.
Afiliação
  • Song S; Department of Clinical Medicine, The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
  • Bai M; Department of General Surgery, Gansu Provincial Hospital, Lanzhou, Gansu, China.
  • Li X; Department of Clinical Medicine, The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
  • Gong S; Department of General Surgery, Gansu Provincial Hospital, Lanzhou, Gansu, China.
  • Yang W; Department of General Surgery, Gansu Provincial Hospital, Lanzhou, Gansu, China.
  • Lei C; School of Basic Medical Sciences, Evidence-Based Medicine Center, Lanzhou University, Lanzhou, Gansu, China.
  • Tian H; Department of Clinical Medicine, The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
  • Si M; School of Basic Medical Sciences, Evidence-Based Medicine Center, Lanzhou University, Lanzhou, Gansu, China.
  • Hao X; Department of General Surgery, Gansu Provincial Hospital, Lanzhou, Gansu, China.
  • Guo T; School of Basic Medical Sciences, Evidence-Based Medicine Center, Lanzhou University, Lanzhou, Gansu, China.
Expert Rev Mol Diagn ; 22(3): 361-378, 2022 03.
Article em En | MEDLINE | ID: mdl-35234564

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Expert Rev Mol Diagn Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Expert Rev Mol Diagn Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China